Brokerages Set LifeStance Health Group, Inc. (NASDAQ:LFST) PT at $8.50

LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) has been assigned an average rating of "Moderate Buy" from the six ratings firms that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $8.50.

Several research firms have recently weighed in on LFST. KeyCorp began coverage on shares of LifeStance Health Group in a research note on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 target price for the company. UBS Group upgraded shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 target price for the company in a research note on Tuesday, May 27th. Finally, Canaccord Genuity Group began coverage on shares of LifeStance Health Group in a research note on Thursday, April 3rd. They issued a "buy" rating and a $8.00 target price for the company.

Insider Buying and Selling at LifeStance Health Group

In other LifeStance Health Group news, insider Ujjwal Ramtekkar sold 16,000 shares of the stock in a transaction that occurred on Thursday, June 5th. The shares were sold at an average price of $5.94, for a total transaction of $95,040.00. Following the completion of the sale, the insider directly owned 113,435 shares of the company's stock, valued at $673,803.90. This trade represents a 12.36% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 3.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of LFST. DekaBank Deutsche Girozentrale bought a new stake in LifeStance Health Group in the first quarter worth $31,000. Park Edge Advisors LLC bought a new stake in LifeStance Health Group in the second quarter worth $52,000. Xponance Inc. bought a new stake in shares of LifeStance Health Group during the first quarter worth $69,000. Ameriprise Financial Inc. bought a new stake in shares of LifeStance Health Group during the fourth quarter worth $87,000. Finally, Kapitalo Investimentos Ltda bought a new stake in shares of LifeStance Health Group during the first quarter worth $87,000. 85.50% of the stock is owned by hedge funds and other institutional investors.

LifeStance Health Group Stock Performance

NASDAQ LFST traded down $0.18 during trading hours on Friday, reaching $4.40. 1,941,756 shares of the company were exchanged, compared to its average volume of 1,697,799. LifeStance Health Group has a 1 year low of $4.38 and a 1 year high of $8.61. The business's 50 day simple moving average is $5.41 and its 200-day simple moving average is $6.65. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 0.19. The stock has a market capitalization of $1.71 billion, a P/E ratio of -43.95 and a beta of 1.16.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.